Journals / Kulak Burun Boğaz İhtisas Dergisi / 2002 / Cilt: 9 - Sayı: 5

The efficacy of combined medical treatment (antihistaminics, steroid, and macrolide antibiotics) in patients with nasal polyposis: Preliminary results

Nazal polipozisli hastalarda kombine antihistaminik, steroid ve makrolid tedavisinin etkinliği: Ön sonuçlar

Pages
352–357
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The overall decrease in the size of the polyps was sig-nificant (p<0.005).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We evaluated the efficacy of combined med-ical treatment in cases with bilateral nasal polyposis without a history of any surgical or medical treatment.
📊
Key Findings & Data:Patients and Methods: Twenty-five patients (19 males, 6 females; mean age 45 years; range 30 to 60 years) who had not received any treatment for bilateral nasal polyposis were included.
💡
Conclusion & Impact:The overall decrease in the size of the polyps was sig-nificant (p<0.005).
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Klaritromisin · Anti-enflamatuvar ajanlar · Histamin H1 antagonistleri

Abstract

Objectives: We evaluated the efficacy of combined med-ical treatment in cases with bilateral nasal polyposis without a history of any surgical or medical treatment. Patients and Methods: Twenty-five patients (19 males, 6 females; mean age 45 years; range 30 to 60 years) who had not received any treatment for bilateral nasal polyposis were included. Treatment was comprised of an oral anti-histaminic agent (single dose daily for 3 weeks), and a topical steroid (as a nasal spray, twice daily for 6 months) and a single dose of intramuscular systemic steroid. Patients who did not respond to this therapy at the end of three weeks were administered a macrolide antibiotic (clarithromycin). The results were evaluated before treatment, and three weeks and six months after treatment with the use of a patient questionnaire, com-puted tomography and endoscopic examination findings. Results: The patients' complaints improved by 85.5% and 79% at the end of three weeks and six months, respectively (p<0.005). Radiologic improvement was found to be 64% at the end of six months (p<0.005). The overall decrease in the size of the polyps was sig-nificant (p<0.005). No treatment-associated complica-tions were encountered. Conclusion: Significant improvement achieved favors the use of combined medical treatment before surgery in selected patients with nasal polyposis.

Özet

Amaç: Önceden medikal veya cerrahi tedavi görmemiş iki taraflı nasal polipozisli olgularda kombine medikal tedavinin etkinliğini değerlendirdik. Hastalar ve Yöntemler: Çalışmaya iki taraflı nasal polipozisli ve önceden ameliyat geçirmeyen 25 hasta (19 erkek, 6 kadın; ort. yaş 45; dağılım 30-60) alındı. Hastalara medikal tedavi olarak oral antihistaminik (günde tek doz, üç hafta), topikal nazal steroidli sprey (günde iki kez, altı ay) ve tek doz intramusküler sistemik steroid uygulandı. Üç haftalık tedaviye yanıt vermeyen hastalara makrolid grubu (klaritromisin) antibiyotik verildi. Hastaların tedaviye yanıtları sübjektif olarak semptomlara yönelik anket formu ile, objektif sonuçlar ise bilgisayarlı tomografi bulguları ve endoskopik muayene skorlarına göre değerlendirildi. Tedaviden sonra üçüncü hafta ve altıncı aydaki sonuçlar, tedavi öncesi bulgularla karşılaştırıldı. Bulgular: Üçüncü hafta ve altıncı ayın sonunda hastaların şikayetlerinde sırasıyla %85.5 ve %79 oranlarında iyileşme görüldü (p<0.005). Altıncı ayın sonunda radyolojik iyileşme oranı %64 bulundu (p<0.005). Polip boyutları, tedavi öncesine göre istatistiksel olarak anlamlı düşüş gösterdi (p<0.005). Tedaviyle ilgili herhangi bir komplikasyonla karşılaşılmadı. Sonuç: İyileşme sonuçları, nazal polipozisli seçilmiş hastalarda cerrahiden önce kombine medikal tedavinin değerlendirilmesi gerektiğini göstermektedir.

🔖

Cite This Article

KURAN, G., KOCATÜRK, S., KURUKAHVECİOĞLU, S., ERKAM, Ü. (2002). The efficacy of combined medical treatment (antihistaminics, steroid, and macrolide antibiotics) in patients with nasal polyposis: Preliminary results. Kulak Burun Boğaz İhtisas Dergisi, Cilt: 9 - Sayı: 5, 352–357. https://ajindex.com/articles/343137

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Drake-Lee AB. Nasal polyps. In: Kerr AG, editor. Scott-Brown's otolaryngology. Vol. 4, 6th ed. London: Butterworth-Heinemann, Reed Educational and Professional Publishing; 1997. p. 1-10
  2. Larsen PL, Tos M. Origin of nasal polyps. Laryngoscope 1991;101:305-12
  3. Settipane GA, Klein DE, Settipane RJ. Nasal polyps. State of the art. Rhinol Suppl 1991;ll:33-6
  4. Frenkiel S, Chagnon F, Small P, Rochon L, Cohen C, Black M. The immunological basis of nasal polyp formation. J Otolaryngol 1985;14:89-91
  5. Holmberg K, Karlsson G. Nasal polyps: medical or surgical management? Clin Exp Allergy 1996;26 Suppl 3: 23-30
  6. Radenne F, Lamblin C, Vandezande LM, Tîllie-Leblond I, Darras J, Tonnel AB, et al. Quality of life in nasal polyposis. J Allergy Clin Immunol 1999;104:79-84
  7. Mosges R, Klimek L. Azelastine reduces mediators of inflammation in patients with nasal polyps. Allergy Asthma Proc 1998;19:379-83
  8. Kutting B, Nieschalk M, Brehler R. A new concept for treatment of sinonasal polyposis. Allergy 2000;55:1091-2
  9. Mygind N. Effects of corticosteroid therapy in non-allergic rhinosinusitis. Acta Otolaryngol 1996;116:164-6
  10. Settipane GA. Nasal polyps: epidemiology, pathogenesis and treatment. 5th ed. Rhode Island: Ocean Side Publications; 1997
  11. Mygind N, Lildholdt T. Nasal polyps treatment: medical management. Allergy Asthma Proc 1996;17:275-82
  12. Nonaka M, Pawankar R, Saji F, Yagi T. Effect of roxithromycin on IL-8 synthesis and proliferation of nasal polyp fibroblasts. Acta Otolaryngol Suppl 1998;539:71-5
  13. Suzuki H, Shimomura A, Ikeda K, Furukawa M, Oshima T, Takasaka T. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasalepithelial cells. Laryngoscope 1997;107:1661-6
  14. Cervin A. The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. Acta Otolaryngol 2001; 12:83-92
  15. Vendelo Johansen L, Ilium P, Kristensen S, Winther L, Vang Petersen S, Synnerstad B. The effect of budespnide (Rhinocort) in the treatment of small and medium-sized nasal polyps. Clin Otolaryngol 1993;18:524-7
  16. Lund VJ, Mackay IS. Staging in rhinosinuşitus.Rhinology 1993;31:183-4
  17. Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope 1992;102 (12 Pt 2 Suppl 57):1-18
  18. Rice DH. Endoscopic sinus surgery: results at 2-year followup. Otolaryngol Head Neck Surg 1989;101:476-9
  19. Wigand ME, Hosemann WG. Results of endosc